Vous n'êtes pas identifié (connexion)

Centre de recherche

MERCREDI 22 NOV

Calendrier >

BOTTIN

Marie-Louise Vachon

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Maladies infectieuses et immunitaires
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
R-0709
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-525-4444, poste 42705
Télécopieur(s)
+1 418-654-2715
Courriel(s)

Projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Feld JJ, Ramji A, Shafran SD, Willems B, Marotta P, Huchet E, Vachon ML, Svarovskaia ES, Huang KC, Hyland RH, Yun C, Massetto B, Brainard DM, McHutchison JG, Tam E, Bailey R, Cooper C, Yoshida EM, Greenbloom S, Elkhashab M, Borgia S, Swain MG. Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2017. Epub
Young J, Rossi C, Gill J, Walmsley S, Cooper C, Cox J, Martel-Laferriere V, Conway B, Pick N, Vachon ML, Klein MB, Canadian Co-infection Cohort Investigators. Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2017. 64: 1154-1162
Rolland S, Vachon ML. Sofosbuvir for the treatment of hepatitis C virus infection. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,  2015. 187: 203-4
Parikh ND, Martel-Laferriere V, Kushner T, Childs K, Vachon ML, Dronamraju D, Taylor C, Fiel MI, Schiano T, Nelson M, Agarwal K, Dieterich DT. Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm. The Journal of infectious diseases,  2014. 209: 734-8
Beauchamp E, Rollet K, Walmsley S, Wong DK, Cooper C, Klein MB, Canadian Co-infection Cohort Study (CTN222). Missed opportunities for hepatocellular carcinoma screening in an HIV/hepatitis C virus-coinfected cohort. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2013. 57: 1339-42
Dyvorne HA, Galea N, Nevers T, Fiel MI, Carpenter D, Wong E, Orton M, de Oliveira A, Feiweier T, Vachon ML, Babb JS, Taouli B. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters--a pilot study. Radiology,  2013. 266: 920-9
Vachon ML, Dieterich DT. Gastrointestinal disorders in HIV including diarrhea (Chapter 18) In: Volberding P, Sande, Merle A., Medical management of AIDS, eds.  Sande’s HIV/AIDS medicine : medical management of AIDS 2013 [Philadelphia, Pa.?]: Elsevier / Saunders, 2012. p.237-248.
Branch AD, Van Natta ML, Vachon ML, Dieterich DT, Meinert CL, Jabs DA, Studies of the Ocular Complications of AIDS Research Group. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2012. 55: 137-44
Vachon ML. BI-201335. Treatment of hepatitis C virus serine protease NS3/non-structural protein 4A (NS4A) inhibitor Drugs of the future,  2012. 37: 99-109
Vachon ML, Dieterich DT. A great time to invest in baby Boomer's hepatitis C! Hepatology (Baltimore, Md.) ,  2012. 56: 1575-7
© 2017 Tous droits réservés Centre de recherche du CHU de Québec